|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net income | |||||
| Loss from discontinued operations, net of tax | |||||
| Income from continuing operations | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Bridge loan facility fees | |||||
| Depreciation and amortization | |||||
| Employee share-based compensation expense | |||||
| Financing costs amortization | |||||
| Realized gain on equity method investment | |||||
| Unrealized foreign currency transaction loss (gain) | |||||
| Unrealized loss (gain) on investments in equity securities | |||||
| Equity in (earnings) loss of unconsolidated affiliates | |||||
| Deferred income tax benefit | |||||
| Other non-cash operating activities | |||||
| Changes in assets and liabilities, net of acquisitions: | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Unbilled contract revenue | |||||
| Prepaid expenses and other current assets | |||||
| Accounts payable and other current liabilities | |||||
| Customer advances and billings in excess of contract revenue | |||||
| Termination fee paid by Baker Hughes | |||||
| Long-term assets and liabilities | |||||
| Net Cash Provided By Continuing Operating Activities | |||||
| Net Cash Used In Discontinued Operating Activities | |||||
| Net Cash Provided By Operating Activities | |||||
| INVESTING ACTIVITIES | |||||
| Acquisition of business, net of cash acquired | |||||
| Proceeds from sale of businesses, net of cash divested | |||||
| Capital expenditures | |||||
| Investments | |||||
| Cash received from settlement of cross-currency swap agreement | |||||
| Proceeds from sale of assets | |||||
| Government grants and other | |||||
| Other investing activities | |||||
| Net Cash Used In Continuing Investing Activities | |||||
| Net Cash Used In Discontinued Investing Activities | |||||
| Net Cash Used In Investing Activities | |||||
| FINANCING ACTIVITIES | |||||
| Borrowings on senior secured and senior unsecured notes | |||||
| Borrowings on credit facilities | |||||
| Repayments on credit facilities | |||||
| Repayment of convertible notes | |||||
| Borrowings on term loan | |||||
| Repayments on term loan | |||||
| Payments for debt issuance costs | |||||
| Payment of contingent consideration | |||||
| Proceeds from issuance of common stock, net | |||||
| Proceeds from issuance of preferred stock, net | |||||
| Payments for equity issuance costs | |||||
| Proceeds from exercise of stock options | |||||
| Common stock repurchases from share-based compensation plans | |||||
| Dividend distribution to noncontrolling interests | |||||
| Dividends paid on mandatory convertible preferred stock | |||||
| Other financing activities | |||||
| Net Cash (Used in) Provided By Financing Activities | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Net increase (decrease) in cash, cash equivalents, restricted cash, and restricted cash equivalents | |||||
| Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation, Beginning Balance | |||||
| CASH, CASH EQUIVALENTS, RESTRICTED CASH, AND RESTRICTED CASH EQUIVALENTS AT END OF PERIOD | |||||
Loading...